Theolair tablets ve Azaltılmış boşluk
Theolair tablets ilacının Azaltılmış boşluk hastalığı ile etkileşiminin güvenlik kontrolünün sonucu.
Drugs.com, Rxlist.com, Webmd.com, Medscape.com gibi yetkili kaynaklara dayalı kontrolün sonucunda bu ilacın bu komorbid hastalık ile etkileşmesi halinde zarar verebilen veya olumsuz etkisini artırabilen kontrendikasyonlar veya yan etkiler bulundu.
Tüketici:Belirli koşullar azaltılmış teofilin klerensi nedenleri olarak tespit edilmiştir. Yaş (yenidoğan ve bebekler < 1 yıl gibi yaşlı hastalarda > 60 yıl) ve aşağıdaki eşzamanlı hastalıklar: akut pulmoner ödem; sinde kalp yetmezliği, cor bulunmamıştır; 24 saat veya daha fazla, daha uzun süre veya daha az sıcaklık yükselme için ateş (>= 102 derece); grip; tedavi edilmemiş veya kontrol edilemeyen hipotiroidizm, karaciğer hastalığı, siroz veya hepatit; bebeklerde azalmış böbrek fonksiyon 3 aydan sonra<; sepsis, multi-organ yetmezliği; ve şok vardır. Theophyllines ile tedavi dikkatle bir daha bu risk faktörlerinin bir veya hastalarda uygulanmalıdır ve doz uygun şekilde zehirlenmesi önlemek için azaltılmalıdır. Serum teofilin Konsantrasyonu daha yoğun izleme gerekli olabilir. Toksisite düzeyleri 20 mcg/mL aştığında ortaya en olasıdır. Ciddi durumlarda, bazen önceki uyarı olmadan, kardiyak aritmi, dirençli nöbetler ve ölüme yol açtı.
- O'Connor P, Feely J "Clinical pharmacokinetics and endocrine disorders. Therapeutic implications." Clin Pharmacokinet 13 (1987): 345-64
- Kraan J, Jonkman JH, Koeter GH, et al "The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease." Eur J Clin Pharmacol 35 (1988): 357-62
- Staib AH, Schuppan D, Lissner R, Zilly W, von Bomhard G, Richter E "Pharmacokinetics and metabolism of theophylline in patients with liver diseases." Int J Clin Pharmacol Ther Toxicol 18 (1980): 500-2
- Shannon M "Predictors of major toxicity after theophylline overdose." Ann Intern Med 119 (1993): 1161-7
- "Product Information. Theo-Dur (theophylline)." Schering Laboratories, Kenilworth, NJ.
- Jeong CS, Hwang SC, Jones DW, Ryu HS, Sohn K, Sands CD "Theophylline disposition in korean patients with congestive heart failure." Ann Pharmacother 28 (1994): 396-401
- Au WY, Dutt AK, DeSoyza N "Theophylline kinetics in chronic obstructive airway disease in the elderly." Clin Pharmacol Ther 37 (1985): 472-8
- Schiff GD, Hegde HK, LaCloche L, Hryhorczuk DO "Inpatient theophylline toxicity: preventable factors." Ann Intern Med 114 (1991): 748-53
- Amodio P, Lauro S, Rondana M, et al "Theophylline pharmacokinetics and liver function indexes in chronic liver disease." Respiration 58 (1991): 106-11
- Vicuna N, McNay JL, Ludden TM, Schwertner H "Impaired theophylline clearance in patients with cor pumonale." Br J Clin Pharmacol 7 (1979): 33-7
- Blouin RA, Erwin WG, Foster TS, Scott S "Pharmacokinetics of theophylline in young and elderly subjects." Gerontology 28 (1982): 323-7
- Jenne JW "Effect of disease states on theophylline elimination." J Allergy Clin Immunol 78 (1986): 727-35
- Vozeh S, Otten M, Staub JJ, Follath F "Influence of thyroid function on theophylline kinetics." Clin Pharmacol Ther 36 (1984): 634-40
- Pokrajac M, Simic D, Varagic VM "Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease." Eur J Clin Pharmacol 33 (1987): 483-6
- Covelli HD, Knodel AR, Heppner BT "Predisposing factors to apparent theophylline-induced seizures." Ann Allergy 54 (1985): 411-5
- Milgrom H, Bender B "Current issues in the use of theophylline." Am Rev Respir Dis 147 (1993): s33-9
- Aderka D, Shavit G, Garfinkel D, et al "Life-threatening theophylline intoxication in a hypothyroid patient." Respiration 44 (1983): 77-80
- Kuntz HD, Straub H, May B "Theophylline elimination in congestive heart failure." Klin Wochenschr 61 (1983): 1105-6
- Clark BG, Vestal RE "Adverse drug reactions in the elderly: case studies." Geriatrics 39 (1984): 53-4,60-3,66
- Dal Negro R, Turco P, Pomari C, Monici-Preti P "Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation." Int J Clin Pharmacol Ther Toxicol 25 (1987): 401-5
- Sessler CN "Theophylline toxicity: clinical features of 116 consecutive cases." Am J Med 88 (1990): 567-76
- Shin SG, Juan D, Rammohan M "Theophylline pharmacokinetics in normal elderly subjects." Clin Pharmacol Ther 44 (1988): 522-30
- Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI "Theophylline disposition in patients with hepatic cirrhosis." N Engl J Med 296 (1977): 1495-7
- Ogilvie RJ "Clinical pharmacokinetics of theophylline." Clin Pharmacokinet 3 (1978): 267-93
- Hendeles L, Weinberger M, Johnson G "Monitoring serum theophylline levels." Clin Pharmacokinet 3 (1978): 294-312
- Albert S "Aminophylline toxicity." Pediatr Clin North Am 34 (1987): 61-73
- Jackson SH, Johnston A, Woollard R, Turner P "The relationship between theophylline clearance and age in adult life." Eur J Clin Pharmacol 36 (1989): 29-34
Jenerik adı: theophylline
Marka adı: Elixophyllin, Theo-24, Respbid, T-Phyl, Aerolate III, Slo-Bid Gyrocaps, Slo-Phyllin, Theobid, Theo-Dur, Theolair, Theovent, Bronkodyl, Theo-X, Theo-Time, Theochron, Slo-Phyllin 125, Theoclear LA-130, Aerolate JR, Theolair-SR, Theoclear LA-260, Quibron-T, Quibron-T/SR, Uniphyl, Uni-Dur, Aerolate SR, Slo-Phyllin 80, Theoclear-80, Theo-Dur Sprinkles, Theosol-80, Asmalix, Aquaphyllin, Truxophyllin, Slo-Phyllin 250, TheoCap
Eşdeğer ilaçlar: Theolair
Theolair tablets - zmniejszony prześwit 
Theolair tablets - folga reduzida 
Theolair tablets - pelepasan dikurangkan 
Theolair tablets - izin berkurang 
Theolair tablets - gioco ridotto 
Theolair tablets - jeu réduit 
Theolair tablets - reduzierter Abstand 
Theolair tablets - espacio libre reducido 
Theolair tablets - уменьшенный клиренс 
Theolair tablets - reduced clearance 
Theolair tablets - انخفاض التخليص 
Theolair tablets - 减少的间隙